- SOBRsafe, developer of advanced alcohol detection and monitoring technology, has, after its recent expansion into the behavioral health market, already secured 35 new customer accounts year-to-date
- The company recently unveiled a national campaign targeting more than 45,000 behavioral health decision makers across the country
- The campaign is now expected to significantly build the SOBRsafe brand, grow demand and increase the company’s market share
SOBRsafe (NASDAQ: SOBR), the developer of advanced transdermal alcohol detection and monitoring technology, has made substantial progress in 2024. The company has secured 35 new customer accounts this year, a substantial increase over 2023. The success followed the company’s late 2023 decision to focus on the behavioral health market.
“We first entered our core market of behavioral health in Q4 2023, where our technology is re-inventing the continuum of care by reducing redundancy, eliminating paper trails, creating digital records, improving billing processes, and most importantly, creating more time and focus for clinical practice,” said SOBRsafe CEO and Chairman Dave Gandini in an Aug. 12 press release (https://ibn.fm/80CpT).
Gandini observes that the validation in this new market not only aligns with the company’s sales strategy but is also “the first and most important step in building our industry brand.” He further noted that it empowers the “range of continued customer adoption – from single location providers with fewer than 25 patients, to providers with multiple facilities and larger patient populations.”
Encouraged by the understanding that the market validation enjoyed so far empowers even more customer adoption, the company recently launched a national campaign targeting behavioral health providers. SOBRsafe is undertaking the campaign in partnership with prominent national agencies drawn from the public relations and digital and social media marketing spaces. The campaign seeks to introduce the SOBRsafe(TM) technology to a large and growing market, and is designed to capture over 4 million projected views over the next year and present the technology to more than 45,000 behavioral health decision makers (https://ibn.fm/b2dYO).
“Consistent with our strategy, we established our technology in the behavioral health vertical with our first revenue-generating customers in 2024. We are working with national communications leaders to build the SOBRsafe brand, grow demand and gain market share. This effort will move us closer to improving patient outcomes and saving lives,” said Gandini of the campaign.
The SOBRsafe(TM) technology is a scalable, patent-pending software platform, which integrates with the company’s non-invasive devices, the SOBRcheck(TM) and SOBRsure(TM), to produce statistical, measurable user and business data.
SOBRcheck is a stationary passive alcohol screening and identity verification device. It features two sensors, one which compares biometric data points from the finger to confirm the user’s identity and another that detects or senses alcohol excreted through the pores of the fingertip. The device provides accurate and instantaneous results and can be connected to the cloud for data aggregation. Additionally, it is hygienic, as it does not require users to provide samples of their blood, urine or saliva.
On the other hand, SOBRsure(TM) is a fitness-style wearable wristband designed for continuous, real-time transdermal alcohol monitoring. It remotely sends geolocation data and removal alerts. And in an industry where stigma can and does affect patients’ ability to look for or continue with treatment and recover, the SOBRsure product is silent and discreet, meaning it easily passes off as any other fitness wristband.
By integrating with these devices, the SOBRsafe software collects and transmits data, presenting it as insights to parents, clinicians, administrators, and more. The company is nonetheless exploring possible integrations with third-party systems and licensing by non-competing companies. SOBRsafe is banking on the fact that its eponymous technology can be deployed across multiple other devices for various uses (https://ibn.fm/ssn88).
For more information, visit the company’s website at www.SOBRsafe.com.
NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at https://ibn.fm/SOBR
